JP2006522336A5 - - Google Patents

Download PDF

Info

Publication number
JP2006522336A5
JP2006522336A5 JP2006509274A JP2006509274A JP2006522336A5 JP 2006522336 A5 JP2006522336 A5 JP 2006522336A5 JP 2006509274 A JP2006509274 A JP 2006509274A JP 2006509274 A JP2006509274 A JP 2006509274A JP 2006522336 A5 JP2006522336 A5 JP 2006522336A5
Authority
JP
Japan
Prior art keywords
nfdp
detecting
antibody
sample
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006509274A
Other languages
English (en)
Japanese (ja)
Other versions
JP4557971B2 (ja
JP2006522336A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/009114 external-priority patent/WO2004091379A2/en
Publication of JP2006522336A publication Critical patent/JP2006522336A/ja
Publication of JP2006522336A5 publication Critical patent/JP2006522336A5/ja
Application granted granted Critical
Publication of JP4557971B2 publication Critical patent/JP4557971B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006509274A 2003-03-31 2004-03-26 血液試料からの神経損傷の評価 Expired - Fee Related JP4557971B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45928603P 2003-03-31 2003-03-31
PCT/US2004/009114 WO2004091379A2 (en) 2003-03-31 2004-03-26 Assessing neuronal damage from blood samples

Publications (3)

Publication Number Publication Date
JP2006522336A JP2006522336A (ja) 2006-09-28
JP2006522336A5 true JP2006522336A5 (enExample) 2007-04-19
JP4557971B2 JP4557971B2 (ja) 2010-10-06

Family

ID=33299668

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006509274A Expired - Fee Related JP4557971B2 (ja) 2003-03-31 2004-03-26 血液試料からの神経損傷の評価

Country Status (10)

Country Link
US (3) US20040241762A1 (enExample)
EP (1) EP1613204B1 (enExample)
JP (1) JP4557971B2 (enExample)
AT (1) ATE440286T1 (enExample)
AU (1) AU2004229317B2 (enExample)
CA (1) CA2520945C (enExample)
DE (1) DE602004022645D1 (enExample)
DK (1) DK1613204T3 (enExample)
ES (1) ES2332136T3 (enExample)
WO (1) WO2004091379A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005113798A2 (en) * 2004-04-15 2005-12-01 University Of Florida Research Foundation, Inc. Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
US20070276275A1 (en) * 2006-05-24 2007-11-29 University Of Miami Screening method and system to estimate the severity of injury in critically ill patients
JPWO2008078809A1 (ja) * 2006-12-27 2010-04-30 独立行政法人科学技術振興機構 鳥類抗体を使用する免疫学的検出方法
US20140038834A1 (en) * 2010-07-07 2014-02-06 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Novel biomarkers for detecting neuronal loss
EP3129780A4 (en) * 2014-04-07 2017-12-13 Iron Horse Diagnostics Inc. Traumatic brain injury and neurodegenerative biomarkers, methods, and systems
CN112823048A (zh) * 2018-07-27 2021-05-18 维拉维斯公司 消除和富集的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86652A1 (de) * 1986-11-10 1988-06-13 Progen Biotechnik Gmbh Verfahren zum auffinden von gewebslaesionen
DE68927459T2 (de) * 1988-12-21 1997-04-24 Gen Hospital Corp Nachweis einer neurologischen Krankheit oder einer Funktionsstörung
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
GB9719879D0 (en) * 1997-09-19 1997-11-19 Neuropa Ltd Protein
US6589746B1 (en) * 1999-10-21 2003-07-08 University Of Cincinnati Method of detecting axonally-derived protein tau in patients with traumatic CNS injury

Similar Documents

Publication Publication Date Title
JP2012509477A5 (enExample)
HRP20201840T1 (hr) Postupci za ocjenjivanje imunološkog odgovora na terapijsko sredstvo
JP2007532915A5 (enExample)
JP2006502416A5 (enExample)
JP2007525427A5 (enExample)
DE60136034D1 (de) Molekular-Modifikations-Assays
WO2005059547A3 (en) Assay
JP2004528574A5 (enExample)
RU2010153316A (ru) Устройство и способы детектирования аналитов в слюне
CA2747253A1 (en) Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd
RU2011125320A (ru) Способы, устройства и наборы для детекции или мониторинга острого повреждения почек
JP2008503720A5 (enExample)
JP2006517788A5 (enExample)
JP2007523644A5 (enExample)
JP2009531679A5 (ja) 複合タンパク質混合物中の被分析タンパク質および/または被分析ペプチドを検出および/または濃縮するための方法
JP2007502837A5 (enExample)
RU2011140807A (ru) Способ детекции дегенеративных мышечных заболеваний и способ определения терапевтической эффективности при заболеваниях
CN103091496A (zh) 免疫测定试剂、生物传感器和检测分析物的方法
HRP20201418T1 (hr) Postupak dijagnoze zaraznog peritonitisa i predviđanje težine i ishoda istog kod ljudi
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
JP2006522336A5 (enExample)
JP2008528995A5 (enExample)
WO2005019831B1 (en) Methods for reducing complexity of a sample using small epitope antibodies
Taneja et al. Plasma and urine biomarkers in acute viral hepatitis E
RU2007145635A (ru) Способ оценки эффективности режима лечения